IDEX Biometrics (IDEX) Q2 2024 earnings summary

Executive summary

• Focused on biometric smart card solutions for payments and access, targeting banks, issuers, enterprises, and governments, with expanded use cases including accessibility for the visually impaired and closed-loop payment systems.

• Achieved key milestones in biometric card commercialization, including Mastercard approval for a partner and new market launches in Asia, Europe, Turkey, UK, and another South Asian country.

• Transitioned revenue base entirely to new products, IDEX Pay and IDEX Access, with no legacy component sales.

• Operational efficiencies implemented, including US facility closures, engineering consolidation in Europe, and staff reductions.

• Secured $4.8–$5 million in new financing to support commercialization, with additional warrants for up to $5 million.

Financial highlights

• Q2 2024 revenue was $0.4 million, flat sequentially but down 76% year-over-year due to business model transition.

• Gross margin improved to 40% in Q2 2024 from 26% in Q2 2023, driven by higher software content and solution sales.

• Operating expenses reduced to $5 million, including $1.1 million in restructuring charges; further reductions expected by Q4 2024.

• Net loss for Q2 2024 was $6.9 million (loss per share $0.02); cash balance at June 30, 2024 was $2.1 million.

• 5:1 share consolidation (reverse split) effective January 2024.

Outlook and guidance

• Q3 revenue expected to be below internal expectations due to paused bank launches in Bangladesh amid social unrest.

• Full effect of cost reductions to be realized in Q4, targeting $2.5 million in quarterly operating expenses.

• Revenue and margins anticipated to grow in H2 2024 as partners complete product qualifications and launch biometric cards.

• Shorter sales cycles and higher volume requests expected as the market matures.